Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

First clinical experiences with ORG NC 45.

J F Crul, L H Booij

    British Journal of Anaesthesia
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    The novel steroid muscle relaxant Org NC 45 offers a significantly shorter onset and recovery time compared to pancuronium bromide. This new agent demonstrated no cumulative effects or adverse cardiovascular changes in clinical trials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    1986 meeting of the international committee for prevention of anesthesia mortality and morbidity.

    Canadian journal of anaesthesia = Journal canadien d'anesthesie·2010
    Same author

    [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].

    Der Anaesthesist·2008
    Same author

    Comparison of the effects and disposition kinetics of lidocaine and (+/-)prilocaine in patients undergoing axillary brachial plexus block during day case surgery.

    Clinical drug investigation·2008
    Same author

    Rocuronium: high risk for anaphylaxis?

    British journal of anaesthesia·2002
    Same author

    Is succinylcholine appropriate or obsolete in the intensive care unit?

    Critical care (London, England)·2001
    Same author

    Model-based administration of inhalation anaesthesia. 1. Developing a system model.

    British journal of anaesthesia·2001

    Area of Science:

    • Anesthesiology
    • Pharmacology

    Background:

    • Pancuronium bromide is a commonly used neuromuscular blocking agent.
    • There is a need for short-acting muscle relaxants with favorable safety profiles.

    Purpose of the Study:

    • To evaluate the clinical efficacy and safety of the new short-acting steroid muscle relaxant Org NC 45.
    • To compare Org NC 45 with pancuronium bromide in terms of onset, duration, and recovery from neuromuscular blockade.

    Main Methods:

    • Clinical trial involving 18 patients receiving Org NC 45.
    • Comparative analysis with 22 patients receiving pancuronium bromide.
    • Assessment of neuromuscular blocking characteristics and cardiovascular effects.

    Main Results:

    • Org NC 45 demonstrated significantly shorter onset, duration, and recovery times compared to pancuronium bromide.

    Related Experiment Videos

  • No cumulative effects were observed with repeated doses of Org NC 45.
  • Org NC 45 was well-tolerated, with no significant tachycardia or arterial pressure changes observed even at doses three times the effective blocking level.

    • Conclusions:

    • Org NC 45 is a promising short-acting steroid muscle relaxant with a favorable pharmacokinetic and safety profile.
    • Its rapid onset and recovery make it a potentially advantageous alternative to pancuronium bromide in clinical practice.